Phospho-NTRK1 (Y791) Antibody

NTRK1 Structure and Biological Function

NTRK1, also known as TrkA, functions as a high-affinity receptor for nerve growth factor (NGF) and plays a crucial role in the development and maintenance of both central and peripheral nervous systems. The receptor exists as a transmembrane protein with an extracellular domain that binds neurotrophins and an intracellular tyrosine kinase domain responsible for signal transduction . Upon NGF binding, NTRK1 undergoes dimerization and autophosphorylation at specific tyrosine residues in the activation loop of the kinase domain (Y676, Y680, and Y681), which is required for receptor activation . This activation triggers subsequent phosphorylation of additional tyrosine residues, including Y496 and Y791, which serve as docking sites for cytoplasmic adaptor proteins and enzymes . NTRK1 is primarily expressed in neuronal tissues through its TrkA-I isoform (796 residues), while non-neuronal tissues express the TrkA-II isoform (790 residues) that responds only to NGF and not neurotrophin-3 .

Significance of the Y791 Phosphorylation Site

The phosphorylation of tyrosine 791 represents a critical regulatory event in NTRK1 signaling with significant downstream consequences. When phosphorylated, Y791 creates a specific binding site for phospholipase C-gamma (PLCγ), directly facilitating its recruitment and activation . This interaction initiates a signaling cascade resulting in increased calcium levels and activation of calcium/calmodulin-regulated protein kinases, ultimately influencing neuronal differentiation . Research has demonstrated that Y791 phosphorylation operates in parallel with Y496 phosphorylation, which primarily drives SHC-transforming protein (SHC) and fibroblast growth factor receptor substrate 2 (FRS2) recruitment and activation . These distinct phosphorylation sites coordinate different aspects of NTRK1 signaling, with Y791 particularly important for PLCγ-dependent calcium signaling that contributes to neuronal plasticity and survival . Alterations in this phosphorylation site may potentially contribute to pathological conditions, including certain neurodevelopmental disorders and cancer.

Production and Immunogen Characteristics

Phospho-NTRK1 (Y791) antibody is typically produced in rabbits immunized with a synthetic phosphopeptide derived from human NTRK1 protein surrounding the phosphorylation site of tyrosine 791 . The immunogen consists of amino acid residues 747-796 of human TrkA, which is strategically designed to ensure high specificity for the phosphorylated form of the protein . Most commercial preparations of this antibody undergo affinity purification using epitope-specific immunogen chromatography to remove non-specific antibodies and enhance detection sensitivity . The resulting antibody preparations are polyclonal in nature, recognizing multiple epitopes of the phosphorylated region, which can provide robust signal detection across different experimental contexts . The production process typically yields high-affinity antibodies with minimal cross-reactivity to unphosphorylated NTRK1 or other related proteins, making them valuable for studying the specific activation state of the receptor .

Specificity and Cross-Reactivity Profile

The Phospho-NTRK1 (Y791) antibody demonstrates high specificity for the NTRK1 protein when phosphorylated at the Y791 position, with minimal cross-reactivity with unphosphorylated forms or other phosphorylated proteins . Most commercial preparations are validated to react primarily with human NTRK1, though some preparations also demonstrate cross-reactivity with mouse and rat orthologs due to the high conservation of this phosphorylation site across species . The binding sequence is typically characterized as "PVyLD," where the lowercase "y" represents the phosphorylated tyrosine residue . Manufacturers commonly perform specificity validation using peptide competition assays, where pre-absorption of the antibody with the immunogen peptide results in signal elimination in immunohistochemistry or western blot applications . Cross-reactivity testing with other phosphorylated tyrosine kinase receptors confirms the selectivity of these antibodies for the phospho-Y791 epitope of NTRK1, making them reliable tools for studying specific activation states of this receptor in complex biological samples .

Physical and Chemical Properties

Commercial preparations of Phospho-NTRK1 (Y791) antibody are typically provided in liquid form with carefully formulated buffer systems to maintain stability and activity. The standard formulation consists of phosphate-buffered saline (PBS) containing 50% glycerol as a cryoprotectant, 0.5% bovine serum albumin (BSA) as a stabilizing protein, and 0.02% sodium azide as a preservative . The antibody concentration is generally standardized at 1 mg/ml, allowing for consistent application across different experimental protocols . The molecular weight of the target NTRK1 protein is approximately 87-140 kDa, with variability due to different glycosylation states that produce the mature functional 140 kDa glycoprotein . The IgG isotype of these rabbit polyclonal antibodies confers appropriate binding characteristics and compatibility with secondary detection systems commonly used in immunological techniques . These physical and chemical properties ensure reliable performance in various applications while maintaining stability during storage and handling.

Immunohistochemistry Applications

Phospho-NTRK1 (Y791) antibody is widely employed in immunohistochemistry (IHC) to visualize the spatial distribution of activated NTRK1 receptors in tissue sections. For IHC applications, the recommended dilution range is typically 1:100-1:300, though optimal concentrations should be determined through titration experiments for specific tissue types and fixation methods . The antibody performs effectively in both paraffin-embedded (IHC-p) and frozen sections (IHC-f), with antigen retrieval often required for formalin-fixed tissues using high-temperature Tris-EDTA buffer at pH 8.0 . Validation studies using human tissues such as brain and breast cancer samples have demonstrated specific staining patterns that can be completely abolished by pre-incubation with the phospho-peptide immunogen, confirming staining specificity . When interpreting IHC results, it's important to note that phosphorylated NTRK1 may localize to multiple cellular compartments, including the plasma membrane, early endosomes, late endosomes, and recycling endosomes, reflecting the dynamic trafficking of the activated receptor following neurotrophin binding .

Enzyme-Linked Immunosorbent Assay

In enzyme-linked immunosorbent assay (ELISA) applications, Phospho-NTRK1 (Y791) antibody provides a sensitive method for quantitative detection of phosphorylated NTRK1 in cell and tissue lysates. The recommended dilution for ELISA applications is typically 1:5000, reflecting the high sensitivity of this format . Manufacturers have validated these antibodies for use in both direct ELISA formats, where the antibody binds directly to immobilized antigens, and in sandwich ELISA configurations, where the phospho-specific antibody is used in conjunction with total NTRK1 antibodies to determine the ratio of phosphorylated to total receptor . For quantitative phosphorylation studies, commercially available sandwich ELISA kits incorporating phospho-NTRK1 (Y791) antibodies can detect subtle changes in receptor activation following ligand stimulation or pharmacological intervention . When designing ELISA experiments, researchers should ensure that samples contain phosphatase inhibitors during preparation to preserve the phosphorylation status of NTRK1, as this post-translational modification can be rapidly lost during cell lysis and protein extraction .

Western Blotting and Additional Applications

Phospho-NTRK1 (Y791) antibody is extensively validated for western blotting applications, enabling detection of the phosphorylated receptor in complex protein mixtures separated by electrophoresis. For western blot applications, recommended dilutions typically range from 1:500 to 1:3000, with the optimal concentration dependent on protein loading and detection method . When performing western blots, it's advisable to use 6% Tris-glycine gels to effectively resolve the high molecular weight NTRK1 protein (87-140 kDa) . Beyond standard applications, some Phospho-NTRK1 (Y791) antibodies have been validated for immunofluorescence (IF) with recommended dilutions of 1:50-200, allowing for subcellular localization studies of activated receptors . For dot blot applications, where native proteins are directly spotted onto membranes, dilutions of approximately 1:500 are typically effective . When designing experiments using these antibodies, researchers should incorporate appropriate controls, including untreated versus neurotrophin-stimulated samples, to confirm the specificity of phosphorylation detection and minimize background signals that could complicate interpretation .

Signal Transduction Mechanisms

The phosphorylation of NTRK1 at Y791 represents a critical node in neurotrophin signaling that initiates distinct downstream pathways essential for neuronal function. Upon NGF binding and receptor dimerization, autophosphorylation of the activation loop (Y676, Y680, Y681) enables subsequent phosphorylation of Y791, creating a specific docking site for phospholipase C-gamma (PLCγ) . The direct interaction between phosphorylated Y791 and PLCγ triggers hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG) . This activation operates in parallel with but distinctly from the pathway initiated by Y496 phosphorylation, which primarily engages the SHC adaptor protein to activate RAS/MAPK and PI3K signaling . The Y791-PLCγ interaction represents one branch of a complex signaling network that includes multiple downstream effectors such as members of the MAPK, PI3K, and protein kinase C (PKC) pathways, all contributing to the diverse cellular responses to neurotrophin stimulation . Through these mechanisms, Y791 phosphorylation plays a central role in translating extracellular neurotrophin signals into intracellular biochemical events that ultimately regulate gene expression.

Functional Consequences in Neuronal Development

Phosphorylation at Y791 of NTRK1 contributes significantly to neuronal development, differentiation, and survival through specific downstream signaling cascades. The PLCγ activity initiated by phosphorylated Y791 leads to increased intracellular calcium levels and activation of calcium/calmodulin-dependent protein kinases, which are crucial for neuronal plasticity and outgrowth . This calcium signaling pathway converges with the RAS/MAPK pathway to induce expression of genes essential for neuronal differentiation, such as those regulated by cyclic AMP-responsive element-binding (CREB) transcriptional co-activator proteins . In developing neurons, the balance between Y496 and Y791 phosphorylation-mediated pathways appears to regulate the switch between survival and differentiation signals, with Y791-PLCγ signaling more closely associated with differentiation outcomes . Studies using NTRK1 mutations in congenital insensitivity to pain with anhidrosis (CIPA) have demonstrated that proper Y791 phosphorylation is essential for normal development of nociceptive and sympathetic neurons, highlighting its physiological importance . These functional consequences underscore the critical role of Y791 phosphorylation in orchestrating complex developmental processes in the nervous system.

Implications in Cancer and Therapeutic Targeting

The activation state of NTRK1, including phosphorylation at Y791, has significant implications for cancer biology and targeted therapeutics. In NTRK fusion-positive cancers, where chromosomal rearrangements create chimeric proteins with constitutively active NTRK kinase domains, aberrant phosphorylation of Y791 can drive uncontrolled PLCγ signaling contributing to oncogenic transformation . The development of TRK inhibitors represents a significant advance in precision oncology, with these agents designed to prevent autophosphorylation and subsequent phosphorylation of sites including Y791, thereby blocking downstream oncogenic signaling . Monitoring the phosphorylation status of Y791 using specific antibodies can serve as a biomarker for TRK inhibitor efficacy in research and potentially clinical settings . Recent studies have also suggested that differential phosphorylation patterns of NTRK1, including at Y791, may influence response to targeted therapies and contribute to mechanisms of acquired resistance . These findings highlight the importance of understanding Y791 phosphorylation not only in normal physiology but also in pathological contexts where it may represent both a biomarker and therapeutic target.

Optimization Strategies for Research Applications

Successful application of Phospho-NTRK1 (Y791) antibody requires careful optimization strategies tailored to specific experimental conditions and research questions. For all applications, preliminary titration experiments are recommended to determine the optimal working concentration, as the suggested dilution ranges (1:100-1:300 for IHC, 1:5000 for ELISA, 1:500-1:3000 for western blotting) serve only as starting points . When designing experiments to detect phosphorylated NTRK1, sample preparation is critical; cells should be serum-starved before neurotrophin stimulation to reduce baseline phosphorylation, and lysis buffers must be supplemented with phosphatase inhibitors to preserve the phosphorylation status during extraction . For immunohistochemistry applications, optimization of antigen retrieval methods is essential, with high-temperature Tris-EDTA buffer (pH 8.0) often providing the best results for formalin-fixed tissues . Inclusion of appropriate positive controls (neurotrophin-stimulated samples) and negative controls (phosphatase-treated samples or peptide competition) is necessary for validating specificity and distinguishing true signals from background . For quantitative studies, normalization to total NTRK1 levels using parallel detection of non-phospho-specific antibodies provides the most informative measure of receptor activation status across experimental conditions .

Performance Evaluation and Selection Criteria

When selecting a Phospho-NTRK1 (Y791) antibody for research applications, several performance criteria should be considered to ensure optimal results. The specificity of the antibody, as demonstrated through peptide competition assays and phosphatase treatment controls, is perhaps the most critical factor in ensuring reliable detection of phosphorylated NTRK1 . Sensitivity constitutes another important consideration, particularly for applications involving low abundance targets or subtle changes in phosphorylation status following experimental treatments . The range of validated applications differs between manufacturers, with some antibodies extensively validated for multiple techniques while others are more specialized for specific applications such as ELISA or western blotting . Cross-reactivity with non-human species may be essential for researchers working with animal models, with some antibodies validated for mouse and rat in addition to human samples . Lot-to-lot consistency represents a significant concern with polyclonal antibodies, making it advisable to request validation data for the specific lot being purchased and to perform in-house validation before conducting critical experiments . Finally, technical support and custom validation services offered by manufacturers can provide valuable assistance in optimizing protocols for specific experimental systems and troubleshooting unexpected results.